Florida legislation · 2026 Regular Session
Florida S596: Transparency in Health Care
Status: Failed, March 13, 2026
Defining the term "personal benefit"; requiring health care practitioners to report any personal benefit received from a pharmaceutical company to the Department of Health; requiring the department to establish uniform reporting procedures and a publicly accessible online database for the reports; requiring the department to establish certain guidelines for health care practitioners, etc.
What the bill says
An act relating to transparency in health care; creating s. 456.0525, F.S.; defining the term âpersonal benefitâ; requiring health care practitioners to report any personal benefit received from a pharmaceutical company to the Department of Health; requiring that such reports be updated at least quarterly and include certain information; requiring the department to establish uniform reporting procedures and a publicly accessible online database for the reports; providing requirements for the database…
From the introduced text, November 19, 2025:
A bill to be entitled An act relating to transparency in health care; creating s. 456.0525, F.S.; defining the term âpersonal benefitâ; requiring health care practitioners to report any personal benefit received from a pharmaceutical company to the Department of Health; requiring that such reports be updated at least quarterly and include certain information; requiring the department to establish uniform reporting procedures and a publicly accessible online database for the reports; providing requirements for the database; requiring the department to establish certain guidelines for health care practitioners; requiring the Auditor General to perform annual audits for specified purposes; providing for administrative and criminal penalties; providing an effective date. Be It Enacted by the Legislature of the State of Florida: Section 1.âSection 456.0525, Florida Statutes, is created to read: 456.0525âDisclosure of personal benefits received from pharmaceutical companies.â (1)âAs used in this section, the term âpersonal benefitâ means any benefit or advantage, economic or noneconomic, received outside of the context of a health care practitioner patient relationship. The term includes, but is not limited to, investment interests, gifts, financial incentives, kickback fees, speaking fees, sponsored travel, research funding, free samples, and any other form of compensation. (2)âTo promote transparency, accountability, and public trust in health care in this state, each health care practitioner shall report to the department any personal benefit received …
Sponsors
- Garcia, Ileana (R, SD-036) · primary sponsor
Latest actions
- : Died in Health Policy
- : Introduced
- : Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
- : Filed
Subjects: Appropriations Committee on Health and Human Services, Fiscal Policy, Health Policy
Common questions
- What is S596?
- S596 is a bill in the Florida Legislature (2026 Regular Session): Transparency in Health Care.
- What does S596 do?
- In its own words: An act relating to transparency in health care; creating s. 456.0525, F.S.; defining the term âpersonal benefitâ; requiring health care practitioners to report any personal benefit received from a pharmaceutical company to the Department of Health; requiring that such reports be updated at least quarterly and include certain information; requiring the department to establish uniform reporting procedures and a publicly accessible online database for the reports; providing requirements for the database…
- What is the status of S596?
- Failed as of March 13, 2026. Latest action: Died in Health Policy (March 13, 2026).
- Who sponsored S596?
- Garcia, Ileana (R, SD-036).
- Where is the official record for S596?
- On the Florida Legislature website: https://www.flsenate.gov/Session/Bill/2026/596
Source: official Florida record. Tracked by Delilah, AI for legislation across all 50 states and Congress.